Rational Advisors’s Exact Sciences EXAS Stock Holding History

Rational Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-16	Closed	-$2K	–	342
2020 Q3	$2K	Buy	+16	New	+$1.38K	﹤0.01%	468

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Rational Advisors's EXAS Position: Q4 2020 in Review

Rational Advisors sold out of Exact Sciences (EXAS) in Q4 2020, closing a stake of 16 shares — an estimated $2K sold.

Rational Advisors first reported a position in EXAS in Q3 2020 and held it in 1 quarter. The position peaked at $2K in Q3 2020. 622 funds tracked by Wall St. Rank hold EXAS as of Q4 2020.

Rational Advisors reported no remaining Exact Sciences position as of Q4 2020 after selling out during the quarter.
Rational Advisors sold 16 Exact Sciences shares in Q4 2020, an estimated $2K.
Rational Advisors first reported a position in Exact Sciences in Q3 2020 and held it in 1 quarter.
Rational Advisors's Exact Sciences position peaked at $2K in Q3 2020.
622 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2020.

Based on Rational Advisors's 13F filing for Q4 2020, filed 5 Feb 2021.